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Abstract
AN INVESTIGATION OF THE EFFECTS OF A DIETARY CALCIUM AND VITAMIN D SUP
PLEMENT ON THE RESORPTION OF THE ALVEOLAR RIDGE OF THE JAW IN IMMEDIATE
DENTURE PATIENTS
by Peter Brussee D.H.Sc.,M.P.H.
The purpose of this study was to investigate the possible effects
of a calcium and vitamin D supplement on the resorption of alveolar
bone following teeth extractions in htaman subjects. Studies have been
cited which indicate a positive relationship between adequacy of cal
cium intake and maintenance of the bones of the jaw.
In this investigation, patients who received dentures immediately
after the extraction of their remaining natural teeth were given a med
ication to take every day for a year.
Half the subjects received a calcium and yitamin D supplement
while half received a placebo. As it was a double—blind study, neither
the subjects nor the investigators knew which subjects had received the
study supplement until after the experiment was over.
Panoramic radiographs of the jaws taken at the beginning and end
of the study period were compared to determine the amount of alveolar
bone resorption which had taken place. Tracings of the radiographs
were measured to obtain quantitative data for statistical purposes.
Analysis of these data revealed significantly less alveolar bone
resorption in the group that received the calcium and vitamin D sup
plement.
In another part of the study, the subjects' dietary calcium intakes,
with or without the supplemental calciimi, were determined, and these
data, along with the dietary Calcium/Phosphorus ratio, were analyzed
to see what correlations might exist between these factors and the ob
served bone resorption.
There was a much less significant correlation between calcium in
take and bone loss, compared to the correlations between supplement in
take and bone loss. This finding suggests that the apparent beneficial
effect of the supplement in reducing or retarding alveolar bone resorp
tion may be attributed to the vitamin D, or to the combination of vitamin
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INTRODUCTION
A Short History of Vitamin D and Calcium Related To Bone Diseases
Vitamin D, calcium, and the related diseases of rickets and osteo-
malacia have a long history, and were subject of intense studies since
100 A.D. where we find the first written description of rickets. In
631564 Lemnius, a physician from The Netherlands, demonstrated that bone
is a living tissue, that it was capable of change, and was sensitive to
78dietary influences. In the sixteenth century when industrialization
started in Europe, rickets appeared more and more frequently. In 1645
78and 1650, Whettler and Gleron were describing and naming the new dis-
78ease—rickets. Schuette in 1814 first reported that cod liver oil is
a possible treatment for rickets. In 1890 and 1916 Palm and Roller^®
recommended sunbaths as a therapy against rickets. In 1919 Sir Edward
Mellanby demonstrated that rickets can be produced artificially by
changing the diet, and that the disease can be prevented by taking cod
49liver oil. Huldshinsky in 1919 reported that rickets can be cured or
prevented through exposure to sunlight or artificial UV light. Orr, et
8X
al, in 1923 measured the fecal loss in rachitic children and recommended
UV light as a cure to increase the absorption of calcium in the intestine.
78
In 1925 McCollum, et al, named the fourth discovered vitamin—vitamin D.
73
Nicolaysen in 1937 demonstrated that vitamin D stimulates calcium ab
sorption from the small intestine but that phosphate absorption would not
be affected by vitamin D. Schachter and Rosen in 1959 studied the
intestinal absorption mechanism of calcium. They found that calcium is
absorbed by active transport that is against a concentration and electrical
gradients, and that this mechanism requires oxygen and a source of energy.
REVIEW OF LITERATURE
Description of Vitamin D
Vitamin D belongs to the group of fat soluble vitamins. Two types
of primary metabolites of vitamin D are well known: ergocalciferol or
vitamin D^j which is the exogenous type of vitamin D that is formed by
the irradiation of ergosterol, and cholecalciferol or vitamin D^, the
endogenous form, which is formed through the irradiation of 7-dehydro-
99
cholesterol.
The structures of the different metabolites of vitamin D are shown
in Fig. 1. There are 40,000 lU to 1 mg of ergocalciferol or cholecal-
74
ciferol. A vitamin D deficiency will result in decreased bone deposi-
108
tion (rickets) which includes an uncalcified seam of the osteoid.
Vitamin D is also considered to be a hormone because active metabolites
of vitamin D are produced at one site of the body (e.g., liver and kid
ney) and transported in the blood stream to act at another location of
75
the body (e.g., small intestine and skeleton).
Vitamin D and Calcium
There is very little vitamin D in common food items, except for
certain fish oils and some vitamin D fortified milk. Since the last
century and maybe earlier, cod liver oil has been advocated as a cure
for rickets. Its efficacy is thought to be due to its high content of
vitamin D. In the U.S. approximately 400 lU of vitamin D per quart is
added to much of the commercially available milk. Because there is
very little vitamin D in food, humans are dependent to a large extent
upon the conversion of 7-dehydrocholesterol into cholecalciferol by ex
posure of the skin to sunlight.
In England before World War II, there was a widespread vitamin D
deficiency among infants. The government then started fortifying the
milk with 7 pg (280 lU) of vitamin D per ounce of milk in 1944. This
fortification program eliminated the rickets but several infants developed
vitamin D poisoning or idiopathic hypercalcemia. The fortification was
74
then reduced to 3 pg or 115 lU per ounce of milk.
The World Health Organization and the Food Agriculture Organization
of the United Nations (1970) recommends an intake of 10 pg (400 lU) of
78 91
vitamin D per day. ' Adults do not need vitamin D supplements under
conditions where they have enough exposure to UV irradiation from sun
shine.
The recommended dietary allowances of calcium for adequate growth in
children between the ages of one to ten is 800 mg; age eleven through
nineteen 1200 mg and for adults 800 mg. During lactation and pregnancy
1200 mg are recommended.
Vitamin D Metabolism
The body receives vitamin D over two different pathways: (1) exog
enous vitamin D by ingestion of dietary vitamin D2 or ergocalciferol;
(2) through endogenous conversion of 7-dehydrocholesterol into cholecal-
99
ciferol.
Exogenous vitamin D2 from dietary sources is absorbed in humans
throughout the entire small intestine in the form of a micelle with the
help of bile salts which appear to be absolutely necessary for the ab-
78sorption of vitamin D2. From the intestinal wall it enters the lymph
80system and is transported with the chylomicrons. As the Ijrmphatic
chylomicrons are assimilated, the largely unaltered vitamin D is then
found to be bound to the serum lipoproteins. On the way to the liver
where most of the vitamin is taken up, its vehicle through the blood
stream is ci62-globulins, which appears to be a specific vitamin D binding
93
protein in the blood stream.
The second source of vitamin D plus its utilization is shown in
Fig. 1: 7-dehydrocholesterol is transformed into cholecalciferol (vita-
80min D^). The source of energy is UV radiation with a wave length
81
between 290-320 m^. The location of this process is in the skin. In
rats a maximal concentration of vitamin is .found in the dead keratin
and in the sebaceous gland fraction. In humans maximal concentrations
were found in the malpighian layer of the skin and very little in the
91
dermis. Cholecalciferol utilizes the same vehicle as ergocalciferol
does to travel through the blood stream to the liver.
Most, approximately 70-75 percent, of the cholecalciferol is taken
84
up by the liver, which may store it or metabolize it to 25-hydroxy-
53
cholecalciferol (25-HCC). Cholecalciferol is the form of vitamin D
utilized for storage. It does not show any significant value as active
metabolite. When 10,000 lU of cholecalciferol were administered into
rat arteries there was no response in initiation of calcium transport
53
from the intestine whatsoever within four hours. 25-HCC, however, is
79
able to initiate calcium transport from the intestine wall. In the same
study, after administration of 2.5 pg of 25-HCC in the same way, calcium
53 92
transport was started after about 1.5 hours. ' The results show that
cholecalciferol, even in high quantities, has very little, if any, effect
on the initiation of calcium absorption from the intestine, while 25-HCC
exhibits very profound effects when given in small quantities.
Cholecalciferol is metabolized exclusively in the liver^^ to 25-
hydroxycholecalciferol. This reaction is catalized by the enzyme chole-
calciferol-25-hydroxylase and, as the name of the enzyme already reveals,
the reaction is hydroxylation, and includes the utilization of oxygen.
An inhibition mechanism controls very carefully the plasma concentra-
48tion of 25—HOC. The concentration of cholecalciferol may increase 100
times while causing an increase of 25-HCC of only three times. This
important finding reveals that the body is taking up and converting
cholecalciferol only as needed. Without this inhibition factor acting
on the enzyme which catalizes this reaction, the body would very soon be
depleted of vitamin D and probably suffer severe hypercalcemia.
25-HCC is the principal circulating form of all the metabolites of
vitamin D in the serum and it is also associated with the Q^^-globulin
89
fraction. As already shown above it represents one of the hormonal
12
active forms and is able to initiate calcium transport from the in-
.  11.12testine.
It was shown that another metabolite of vitamin D exists which is
even more active than 25-HCC; it is 1,25-Dihydroxycholecalciferol. 25-
HCC is transported via the blood stream to the kidneys and metabolized
to 1,25-Dihydroxycholecalciferol (1,25-DHCC) in the mitochondria of the
renal tubules. Other metabolites deriving from 25-HCC are; 25,26-
Dihydroxycholecalciferol (which has some action on the intestine but no
25activity on bone), 24,25-Dlhydroxycholecalclferol, and 21,25-Dihydroxy-
cholecalclferol.^^ The activity of 25,26-DHCC and 21,25-DHCC Is far be
low that of 25-HCC.^^
62Lawson, et al In 1971, found that 1,25—DHCC has a very powerful
action In promoting the absorption of calcium by the Intestinal epithelium.
Nephrectomlzed rats will not produce 1,25-DHCC; this shows that the kid
neys alone are producing this vitamin D metabolite.^® 1,25-DHCC Is the
most active form of all vitamin D metabolites,^^ and Is Involved In bone
calcium mobilization. The enzyme catallzlng the reaction Is 25-HCC-l-
hydroxylase.
Boyle, et al,^^ reported the effect of diet on the production of
1,25-DHCC, He found that when the diet was high In calcium, little 1,25-
DHCC was produced In the kidneys. When the diet was deficient In calcium
the production of 1,25-DHCC was greatly Increased. He reported that when
the production of 1,25-DHCC was depressed, large amounts of the Inactive
metabolite 21,25—DHCC was produced Instead.
A point which will be developed further Is that the production of
^»25-DHCC Is Independent of the presence of parathyroid hormone. The
reaction 25—HCC to 1,25—DHCC can be Inhibited when actlnomycln D^^^ and/or
cyclohexlmlde Is administered to severely vitamin D deficient rats before
25—HCC Is given. When the same process Is done In chickens there Is a
70 percent Inhibition. * Actlnomycln D,* an anticancer drug. Inhibits
the enzyme transcrlptase from transcribing Information from DNA to mRNA
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This fact suggests that the vitamin D metabolite 25-HCC is able to
induce the transcription of genetic information, from DNA to mRNA, re
sponsible for the synthesis of 25-HCC-1-hydroxylase, causing the renal
sjmthesis of 1,25-DHCC. The enzyme responsible for the 25-hydroxylation
of cholecalciferol into 25-HCC does not show any effect on genetic
material. Actinomycin D only appears to block the production of 1,25—
DHCC in the kidney, while it does not block the transport of calcium
from the small intestine which is induced by 1,25—DHCC. Actinomycin D,
however, blocks the intestinal calcium transport mechanism induced by
11225-HCC. This could signify that the calcium transport mechanism in
the intestine elicited in response to 25-HCC includes the involvement
of genetic information.
The Absorption of Calcium From the Intestine
The body receives all of its calcium exclusively from food through
the intestinal mucosa. The absorption of calcium from the intestine is
relatively poor and depends on several factors. In some persons, only
10 to 15 percent of the dietary calcium is absorbed. When vitamin D is
present, the absorption may be increased up to approximately 30 percent.
The uptake of calcium is dependent on the amount of intestinal cal
cium in the ionic state. Also, velocity measurements of calcium uptake
at the surface of the mucosa have shown a dependency on vitamin D; there
fore, the amount of 1,25-DHCC influences the quantity of uptake to a high
degree. Experiments with rats have revealed that there is a maximal
absorption of calcium ions in the initial phase in the proximal gut;
however, as the intestinal content advances it is likely that the cal
cium ion concentration in the fluid diminishes and vitamin D is needed
40
for absorption.
The absorption of calcium is thought to be favored by a high protein
o /
diet; the amino acids lysine and arginine especially promote it. It
is influenced by serum citrate levels; the higher the serum citrate level
the more calcium is absorbed. Lactose in the diet promotes the absorp
tion of calcium.
The absorption of calcium is hindered because of several factors
also. Calcium can bind to phosphates, oxylates, phytates or combine with
fats and become an insoluble soap. All those insoluble compounds pass
through the intestine and are excreted with the feces. Calcium is one
of the bivalent cations, which are poorly absorbed through the intestinal
mucosa. Adrenocortical steroids, such as cortisone, corticosterone,
hydrocortisone, aldosterone, reduce the serum citrate level and thereby
decrease indirectly the absorption of calcium.
The Action of the Vitamin D Metabolite 1,25-DHCC on Intestinal Calcium
Absorption and Calcium Binding Protein
79
Olson and DeLuca, et al, found that in vitamin D deficient rats
a time of twelve hours would pass after the administration of chole-
calciferol until active absorption would start. The answer to the ques
tion of why such a long time is required, lies in the fact that the absorp
tion of calcium depends on four different aspects: (1) the body needs to
convert vitamin into its metabolites 25-HCC, and 1,25-DHCC; (2) the
metabolite 1,25-DHCC has to stimulate the formation of a calcium binding
protein^^ and form the enzymes for the hydroxylation; (3) it also has to
103stimulate the formation of the enzyme ATPase; (4) it finally involves
itself in the initiation of the production of alkaline phosphatase. All
four factors together are related and more or less dependent on the
availability of vitamin D, and influence the rate of absorption of cal
cium from the small intestine.
1»25-DHCC stimulates the intestinal calcium absorption in nephrect-
omized vitamin D deficient rats. The small intestine is lined with villi
whose outer lining consists of columnar epithelial cells. 1,25-DHCC acts
on those cells because those cells are absorbing calcium by the mechanism
70 95of active transport ' against an electrical and a concentration gradient.
This process requires ATP as a source of energy, oxygen and sodium.
42Harrison, et al, demonstrated that soditim ions are required for the cal
cium transport across the intestinal mucosal membrane. Martin and DeLuca^^
refined the work of Harrison and demonstrated that the uptake of calcium
ions from the mucosal membrane into the epithelial cells across the brush
border surface was not dependent on sodium ions in the intestines of rats.
But the release of calcitm ions into the serosal fluid required sodium.
1,25-DHCC stimulates the nuclei of those cells and initiates the
formation of a calcium binding protein (CaBP).^°^ 1,25-DHCC seems to
act on the mucosal membrane, and initiate the synthesis of mEHA
and the formation of the CaBP.^^
The vitamin D induced calcium binding protein was discovered by
Wasserman and Taylor in 1966 by immunofluorescence techniques in the
intestine of chicks, Wasserman, et al, found specific fluorescence in
/ *3
the PAS—positive goblet cells. Helmke and co-workers localized the
CaBP using antiserum and Indirect fluorescent antibody technique for
the localization. They, too, found fluorescence in the goblet cells
but also in the basal and apical parts of the mucosal cells and in the
brush borders of the normal tissue of the small intestine. He attempted
to find CaBP's in stomach, colon, liver, lung, and the skin, but remained
without success. Later Wasserman and Taylor^^^ by means of fluorescent
antibody technique demonstrated that the goblet cells and the surface of
the mucosal membrane contain the bulk of the CaBP's.
The CaBP is synthesized in the cytoplasm of the goblet cells.
29
Drescher and DeLuca (1971) came up with the hypothesis that this CaBP
comes from a pre-existing precursor protein with higher molecular weight.
1»25—DHCC works then on the transformation of this inactive precursor type
of protein into the CaBP. This is a very interesting hypothesis which to
my knowledge remained unconfirmed by other investigators. The CaBP after
its formation is then interspersed in the crypts of the intestinal villi,
78and secreted with mucus that lines the microvilli. There it seems to
integrate itself with the mucosal membrane.
This vitamin D induced intestinal CaBP in humans has a molecular
weight of 12,000 (measured by gel filtration). Its binding capacity of
the four high affinity sites is about 2xlO^H~^. The binding of the
members of the alkaline earth series follows the sequence;
Ca> Sr ? Ba 7
The locations of actions of the CaBP are the intestinal mucosa, the
kidneys, and the mammary gland.
The effect of vitamin on de novo biosynthesis of calcium binding
protein in the chick intestinal mucosa and the temporal relationship
between the synthesis and the stimulation of intestinal calcium transport
by this vitamin was investigated by MacGregor^^ and co—workers. He ad
ministered 20 lU of vitamin doses to vitamin D deficient (rachitic)
chicks at zero time, and H—leucine was injected one or three hours be
fore the animals were killed. Then they purified the CaPP and the amount
3
of H which was incorporated into the CaBP was then determined.
They found that: (1) the biosynthesis of CaBP was stimulated by
the vitamxn several hours before any effect on the intestinal transport
of calcium could be detected; (2) after nine hours ^H-leucine incorpora
tion into pure CaBP was stimulated two to three—fold but there was no
O
effect on calcium transport detected; (3) maximxmi incorporation of H-
leucine into the new synthesis of CaBP was detected at twelve hours;
(4) net synthesis of CaBP and Ca absorption was detected at twelve
hours after the initial administration on 20 lU of vitamin D^; and
(5) after the same time the net increase of CaBP went parallel with the
vitamin D dependent increase in intestinal calcium absorption.
This experiment shows that the synthesis of CaBP is activated be
fore the physiological response of the calcium absorption occurs. It
also shows that the net formation of CaBP increases parallel with the
calcium absorption, and that vitamin D acts on the genetic level causing
the formation of CaBP.
Not only do vitamin D and calcium have an important effect on the
formation of CaBP, but also the intake of protein does, as demonstrated
by Kalk, et al. He put rats on a protein deprivation diet for three
weeks which resulted in a consistently reduced intestinal CaBP activity;
renal CaBP activity was not significantly altered. When he put rats on
a diet deficient in both protein and vitamin D, again a reduced CaBP
activity resulted. When cholecalciferol was administered to those rats,
the CaBP activity doubled but did not come up to the level as in the control
animals. They concluded that in the protein deficient rat: (1) intestinal
^'^bivity is reduced; (2) an additional vitamin D deficiency reduces
the intestinal CaBP activity still further; however, the mucosa retains
the potential to respond when vitamin is given; (3) hepatic metabolism
of cholecalciferol into 25-HCC was unaltered; (4) a reduced CaBP can be
bhe result of a reduced CaBP synthesis as a consequence of deficient
amino acid substrate.
A second factor in the mechanism of intestinal calcium absorption is
the synthesis of a calcium dependent ATPase. Melancon, Jr., et al,^^
suggested an additional calcium absorbing mechanism involving the enzyme
calcium-dependent adinosine triphosphatase which he found to be increased
when vitamin D was administered to vitamin D deficient rats. 1,25-DHCC
stimulates the formation of this Ca—dependent ATPase in the brush borders
of the epithelial cells in rat and chicken intestines. The appearance
of this enzyme activity is induced by 1,25-DHCC at the same time that
1,25-DHCC induces the energy dependent intestinal active calcium transport.
This enzyme requires Mg or Ca for its activity. It can, however,
I  I I I
also be stimulated by Ba and Sr . It has an optimal pH of approximately
467.8-8.9. After the administration of vitamin D in rachitic chicks the
Ca-dependent ATPase revealed no change after a time of 15 hours, however,
increased significantly after 16 to 16.5 hours. Hodsworth, et al,^^
In his research found three enzymes located in the brush borders of the
mucosal cells of the intestine: ATPase, p—nitrophenyl phosphatase, and
py^opliosphatase. He found that those three enzymes approximately double
their activity 48 hours after the administration of 1,25-DHCC. L-phenyl-
alanine was found to inhibit the activity of those three enzymes but did
45not affect the Ca transport from the mucosal to serosal fluid.
The vitamin D metabolite 1,25—DHCC induces the synthesis of the
78enzyme alkaline phosphatase in the epithelial tissue. Alkaline phos
phatase hydrogenates monophosphoric esters causing the liberation of in
organic phosphate. Its concentration in the serum gives an indication
of the rate of bone deposition. The osteoblasts secrete large quantities
of alkaline phosphatase when they are active in depositing bone matrix.
Negative Feedback Mechanism of Calcium Ion Concentration on 1,25-DHCC
The accumulation of 1,25—DHCC is partly regulated by the plasma cal
cium ion concentration. Work on this was accomplished by Boyle, et al,^^
in 1971. A low plasma calcium ion concentration of approximately 9.5 mg%
or lower very promptly turns on the mechanism of increased calcium ab
sorption by a very rapid transport of 1,25-DHCC to the small intestine.
Boyle showed in rats that there is an abrupt change of synthesis of
1,25-DHCC between a plasma calcium concentration of 9-9.6 mg%; when the
calcium ion concentration reaches this level, or if it is higher, the
concentration of 1,25—DHCC drops almost to zero and the rather inactive
metabolite 21,25-DHCC is synthesized in the kidneys instead of 1,25-DHCC.
The mechanism which causes the change of 1-hydroxylation to the 21-
hydroxylation is not understood as yet. This demonstration of the abrupt
change of sjmthesls caused by a very slight increase of the calcium
concentration suggests that the parathyroid hormone is strongly involved
in this feedback control mechanism.
1,25-DHCC
21,25-DHCC
3  4 5 6 7 8 9 10 11 Serum calcium
mg/100ml
Fig. 2. Relationship between the serum calcium concentration and the prod
ucts of kidney 25-HCC hydroxylation. Methods are as described by Boyle,
et al., 1971.
Reabsorption of Calcitim in the Kidney
In the tubules of the kidneys calcium is reabsorbed in the glomerular
filtrate. Therefore, the kidney is the most important collecting point
and regulator of calcium homeostasis. About 4 percent of the total plasma
is filtered by the glomeruli per minute and approximately 98-99.5 percent
of the calcium and about 80-90 percent of the phosphate are reabsorbed.
45Hermsdorf, et al, localized a calcium binding protein in the cortex of
the rat kidney but was not able to find it in the medulla. The molecular
weight of this CaBP In the rat was 28,000, more than twice the vitamin D—
dependent CaBP of the intestinal mucosa of the rat.
Taylor and Wasserman^°° found a CaBP in the kidneys of the chick
which was immunologically identical to the intestinal CaBP and also had
the same molecular weight. When they fed a vitamin D free diet to chicks
and monitored the CaBP content of the kidneys and compared it to the
duodenal CaBP content, they found that CaBP content in the small intestine
decreased very rapidly and was undetectable after two weeks, while the
kidney CaBP content decreased at a much slower rate and amounts could still
be measured after six weeks. Their findings suggest that the kidney CaBP
may play a significant role in the body's calcium ion conservation, and
that vitamin D has a direct effect on the kidney tubules inducing the
synthesis of CaBP. Bar, et al, found that th.e kidney CaBP, when a calcium
restricted diet was fed to chicks, treated either with cholecalciferol or
with 1 ot—hydroxycholecalciferol, increased under dietary phosphorus restric
tion, independently of the kind of vitamin D metabolite. He found a poor
relation between the CaBP activity and the CaBP concentration of the kidney
CaBP. He suggests that the kidney CaBP has a quite different regulation
mechanism than the intestinal CaBP. The concentration of the kidney CaBP
in the renal tissue is related to the renal calcium excretion and/or to
the plasma calcium concentration.
The Role of Vitamin D as a Growth Factor
92Vitamin D is essential for growth. Richards, et al, contributes
the cause of severe "infantile rickets" to a deficiency of vitamin D.
He found a retardation of growth. Changes were brought about by administer
ing 500 lU of vitamin D.
When rats are fed a vitamin D deficient but otherwise perfectly
normal diet (0.7 percent Ca; 0.56 percent P), there is a decrease in
,107 64growth or an arrest in growth but no evidence of rickets, which is
quite hard to induce in the rat by vitamin D deficiency alone. In an
experiment done by Au and Raisz^, rats were fed a vitamin D free diet
and the intake of calcium and phosphorus was varied. They found that a
change in calcium intake from 0.03 percent to 0.4 percent resulted in
a 120 percent increase in body wieght when the phosphorus level in the
diet was kept at 0.1 percent and 0.3 percent respectively. When addi
tional vitamin D was added to the low calcium diet an additional 65 per
cent increase in body weight was observed; the serum calcium level rose
close to normal while the serum phosphate level became normal. The weight
of the experimental rats was still only approximately 65 percent of the
weight of the control group, which was fed a normal calcium diet of 0.4
percent and vitamin D. Optimal growth requires both calcium and vitamin D
in adequate amounts.
Excretion of Vitamin D and of Calcium
Most of the vitamin D metabolites are excreted into the small intes
tine with the bile. Small amounts of vitamin D are excreted into the
urine. About 7/8 of the daily intake of calcium is excreted in the feces,
and the remaining 1/8 (approximately 100—200 mg/day) are excreted into the
urine; 140—175 mg/day are secreted with the bile and pancreatic juices
into the gut; and approximately 20 mg/day are accounted to dermal losses.
vitamin D and the Prevention or Cure of Rickets
Rickets Is a bone disease characterized hlstologlcally by the ac
cumulation of unmlnerallzed hypertrophlc cartilage and osteold^^^ In the
zones of preparatory calcification. Radlographlcally It Is Identified
by the partial to complete absence of mineralization of the skeletal
tissue. It may be diagnosed grossly by severe deformation of the weight
bearing soft and pliable bones, swelling of the joints, and beading of
Is caused by a deficiency of dietary calcium Intake and
calcium transport; a deficiency of vitamin D, or an Increased hydroxyla—
tlon of vitamin Into active metabolites or abnormal low 25-HCC plasma
concentration or a failure of the renal synthesis of 1,25-DHCC. 1,25-DHCC
has the greatest potency In the Induction of bone mobilization and of
calcium transport, but has relatively low potency In curing rickets.
Since 1,25—DHCC mobxllzes calcium from the bone It may even have rickets-
favoring effects. Other Ineffective metabolites are 21,25-HDCC; and
25,26-DHCC. Kruse suggests that long term antlconvulsant therapy In
epilepsy may cause rickets or osteomalacla. Findings Indicate that there
®ust exist another metabolite of vitamin D which Is able to cure rickets.
25—HOC seems to be the most probable metabolite to possess this function
25of an antlrachltlc agent. 25—HOC proved to be 1 1/2 times more effective
on a weight basis than cholecalclferol and It acts faster In Initiating
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calcium transport. '
Wasserman and Taylor, In their work on the calcium binding protein
by Immunofluorescence, could show a lack of CaBP In the Intestine of
rachltlc vitamin D deficient chicks. After they gave vitamin D to those
animals an Immunofluorescence specific for CaBP appeared.
Helmke took biopsies from the small intestine of rachitic children
for examination before he started the treatment with 25-HCC. No or very
weak fluorescence was shown, while the biopsies after the treatment
showed almost normal fluorescence at the base and no fluorescence at the
apical part of the mucosal cells. The fluorescence of the goblet cells
remained unaltered. According to those studies a lack of vitamin D
primarily affects the CaBP content by decreasing its amount, and thus
decreasing the quantity of calcium absorbed from the intestine.
The cure of rickets induced by a deficient diet requires 2000-4000 ITJ
per day of vitamin D for approximately 6-12 weeks.
A very interesting study was done by Wasserman, et al,^^^ on the
25—DHCC-like activity of the calcinogenic plant Oestrum Diurnum,
(Day Blooming Jessamine), which has been causing calcinosis in horses and
cattle in Florida. When he fed to cholecalciferol deficient chicks a
rachitogenic diet, including dried leaf powder from this plant, intestinal
calcium binding protein synthesis was restored and the absorption of cal
cium was increased. The time course of the effect of this plant extract
in rachitic chicks was similar to that of 1,25-DHCC. Also in the strontium
fed chick in which the kidney enzyme 25-HCC-l-hydroxylase is inhibited,
the plant extract responded again like 1,25-DHCC; this confirms the 1,25-
DHCC- like character of this plant. The results show that £. Diurnum may
cause an excessive calcium and phosphate absorption, leading to calcinosis.
Maybe this herb could be of value in treating different bone diseases in
a natural way.
The Role of Parathyroid Hormone
The parathyroid hormone (PTH) is essential for life. Collip,^^ in
1925, was the first who extracted and isolated it. This extract, however,
was not pure enough to permit the analysis of its structure. This struc
tural analysis was accomplished by Brewer and Ronan^^ in 1970. They were
able to isolate an extract pure enough so that structural studies could
be done. According to their results, PTH consists of 84 amino acids and
has a molecular weight of 9,500. It is synthesized from the proparathyroid
hormone in the parathyroid glands. There are three places of activity:
(1) the small intestine; (2) the kidney, a point which was questioned in
the newer literature and will be discussed further below; and (3) in
bone.
Its main function is to maintain a constant normal serum calcium ion
concentration of approximately 9.2-10.4 mg%; its main activity is to in
crease the calcium ion concentration in the plasma. This function is
accomplished by:
(1) The mobilization of calcium salts and, if necessary, of bone
matrix from bone. This function is very much dependent on vitamin
Vitamin D deficient parathyroidectomised rats would not increase their
bone mineralization even after administration of massive amounts of PTH.
Bone mineral mobilization by PTH is also vitamin D dependent.
This function includes: (a) an immediate and rapid activation of all
81osteoclasts that have already been formed; (b) a rapid stimulation to
form new osteoclasts from the mesenchymal cells; (c) a delay in the con
version of osteoclasts into osteoblasts, and finally; (d) a depression of
osteoblastic activity. These mechanisms were found when small living
pieces of parathyroid gland were Implanted adjacent to bone In experimental
animals. The implant caused the development of a great number of osteo—
clasts in the immediate vicinity of the implant and a rapid absorption of
bone tissue. When parathyroid hormone was injected into animals with
severe rickets it was found that the newly formed matrix was reabsorbed
even though no salts were present in the matrix.^®
(2) Parathyroid hormone affects the kidneys by increasing the ex-
ctetion of phosphates into the urine by decreasing the reabsorption of
phosphates in the proximal renal tubules. ^ This action of reabsorption
of phosphates by PTH is independent of the presence of vitamin D since
68it occurs in vitamin D deficiency. PTH causes the Increased excretion
of phosphates while at the same time it enhances increased reabsorption
of calcium and magnesium in the distal renal tubules. Were it not for
the concomitant effect of PTH on the kidneys to increase calcium reabsorp
tion, the continual loss of calcium into the urine would deplete the bone
of its mineral.
(3) Parathyroid hormone increases the intestinal absorption of cal
cium and magnesium but only in the presence of vitamin The
mechanism as already pointed out, is that PTH is to be present in the con
version of 25-HCC to 1,25-DHCC.
(4) Finally, PTH activates the cyclic AMP. Both intracellular
calcium and cyclic AMP affect the production of 1,25-DHCC in the kidney
104tubule. Cyclic AMP enhances the production of 1,25-DHCC.
The question of whether or not the synthesis of 1,25-DHCC in the kid
neys can happen only in the presence of PTH has been quite a point of
90 2 5discussion. Rasmussen, et al, and DeLuca, 1972, showed that the
stimulation and control of the formation of 1,25-DHCC was accomplished by
PTH and cyclic AMP, in isolated renal tubules. He showed that in the
absence of PTH as, e.g., in parathyroidectomized rats 1,25-DHCC is not
formed; however, after the administration of PTH, 1,25-DHCC formation
is induced. Other investigators think that this formation of 1,25-DHCC
is independent from PTH and attribute the findings of Rasmussen and DeLuca
to a factor occurring during the parathyroidectomy of the animals which
caused that type of outcome.
Larkins and co-workers showed that thyroparathyroidectomized rats
are able to increase the production of 1,25-DHCC when the appropriate
dietary stimulus was present.
37Galante involved 28 vitamin D deficient chicks in her study. The
animals were parathyroidectomized and additionally the ultimobranchial
glands were removed. In the fourteen surviving chicks there was no
change in the renal 1-hydroxylase activity for twenty hours after the
37surgery. In another experiment they showed that vitamin D alone de
presses or abolishes 1-hydroxylase activity. Their results showed that
neither calcitonin nor PTH are necessary to maintain or enhance 1-
hydroxylase activity.
The truth might be situated somewhere in the middle. PTH does in
fluence the production of 1,25-DHCC but is not necessary since the kidneys




Calcitonin is a hormone which is produced by the thyroid glands.
Human calcitonin consists of 32 amino acids. Between the AA No. 1 and 7,
there is a disulfide bridge; Prolineamide is present at the carboxyl
33terminus. The normal rate of its secretion is approximately 0.5 mg/
40day. The secretion of calcitonin takes place when the plasma calcium
ion concentration reaches a level of approximately 0.5 mg/100 ml. Above
this level of plasma calcium concentration the plasma calcitonin con
centration appears to be directly proportional to the plasma calcium
level.
The effect of calcitonin in children is much more marked than in
since bone remodeling in children is accomplished much more rapidly
than in adults. Calcitonin has only a weak effect on adult plasma cal
cium ion concentration because the osteoclastic resorption of calcium
provides only 0.8 gm of calcium while in children the osteoclastic re
sorption is 5 gm or more per day.^^
Calcitonin inhibits bone resorption. It reduces the serum calcium
ion concentration in 3 ways: (1) it decreases the activity of the osteo-
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clasts —a large dose of calcitonin is able to decrease osteoclastic
activity by 70 percent in 15 minutes ^ and the number of osteoclasts;^^
(2) within approximately one hour after the administration of calcitonin
the osteoblastic activity is increased and there is a conversion of osteo-
clasts to osteoblasts which lasts a few days.^® Zichner^^^ found that
12 hours after administration of calcitonin osteoblasts in rat tibiae
became multiformed and lined up in two or three layers adjacent to osteoid.
(3) The most prolonged effect of calcitonin is the prevention of forma
tion of new osteoclasts from mesenchymal stem cells.
Calcitonin acts in two ways on the kidneys: (1) it enhances the
excretion of the electrolytes sodium, phosphate, and calcium; and (2) in
the vitamin D metabolism it causes a marked increase in the production of
361»25-DHCC. The difference of action between parathyroid hormone and
calcitonin is that the calcitonin mechanism acts more rapidly reaching
peak activity in less than one hour. In the case of PTH the peak effect
is reached after approximately eight hours. Calcitonin acts as a short-
term regulator and has little long-term effect while PTH acts over long
periods of time.
Bijvoet and co-workers observed that a rapid intravenous injec-
calcitonin could significantly lower plasma calcium and hydroxy—
concentration and urinary hydroxyproline excretion in patients
with increased bone turnover. This observation suggests that since
hydroxyproline excretion is an excellent index of the rate of bone matrix
resorption, that calcitonin noticeably decreases both bone mineral and
O C
matrix resorption in man. DeLuca in 1971 in his experiment gave cal
citonin to severely hypocalcemic rats. The result was that their hypo-
calcemic condition became even worse. The already low plasma concentra
tion of 4 mg% dropped down to approximately 2.7 mg% and in intact animals
the plasma calcium concentration went back to normal levels after four
hours, while in thyroparathyroidectomized rats the serum calcium con—
csntration of 2.7 mg% was maintained during the entire time of the experi
ment. When they administered PTH and calcitonin at the same time the hypo
calcemic effect of calcitonin was eliminated. He could demonstrate by
this study that calcitonin works independently of vitamin D while PTH
does not.
The Regulation of the Concentration of Calcium in the Plasma
The concentration of calcium in the plasma is approximately 10 mg%
and hormally varies between 9.2-10.4 mg% or approximately 5 mEq/liter.
The regulation of plasma calcium is mainly accomplished by para
thyroid hormone. Approximately 50 percent of the plasma calcium is com
bined with the plasma protein. It is not diffusible through capillary
membranes. Approximately 5 percent of the plasma calcium or 0.2 mEq/
is diffusible through the capillary membrane but is combined with
other substances of the plasma and the interstitial fluid (for example:
citrate) in such a way that it is not ionized. Approximately 45 percent
or the rest of the plasma calcium is diffusible through the capillary
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membranes and is ionized.
The plasma and the interstitial fluid have a normal calcium ion con
centration of about 2.3 mEq/liter. This ionic calcium is important and
used for most of the functions of calcium in the body like formation and
maintenance of bones and teeth, transmission of impulses in nerves,
muscle and heart fibers, for muscle relaxation and for normal blood co
agulation. It controls partially the cell wall permeability and acti
vates enzymes like ATPase, lipase, and some peptitases.
When a vitamin D deficient diet is fed to chicks there is a nearly
parallel decrease of serum calcium ion concentration and CaBP in the kid-
112neys; and exception is between day 1-2 while the kidney CaBP increases
slightly while the calcium concentration in serum decreases.
Hypocalcemia
A depletion of calcium ions can lead to tetany. A lack of calcium
ions causes an increased membrane permeability which causes the nervous
system to be more excitable to stimuli. This Increased excitability occurs
In both the central nervous system and In the peripheral nerves. Finally
the nerve fibers become so excitable that they discharge spontaneously
without external stimuli. Those spontaneous nerve Impulses travel to the
peripheral skeletal muscles causing tetanic contractions. If let alone,
those tetanic contractions would kill the patient before anything else
would develop. Tetany normally occurs when the plasma calcium concentra
tion Is as low as 6 mg% or approximately 40 percent below the normal
calcium concentration In plasma. When It drops to 4 mg% or lower It Is
40lethal. Normally, If the calcium loss continues at a high rate, re-
sorptlon of bone tissue occurs to provide the necessary amount of calcium.
The plasma calcium Ion concentration will be maintained at the exact
normal level until finally the bone Is completely depleted of calcium
salts.
Llndholm found, studying the combined effect of calcium and vita
min D deficiency and the effect of an additional bone fracture In rats,
the following results: Those combined factors caused an arrest In growth,
a decrease In serum calcium, and an Increase In serum phosphorus and
phosphatase. The experimental animals reached only half of the weight of
the control group. Hematologlcal results In the control group Indicated
an Increase In the leukocyte count two to three weeks after the bone
fracture. In the experimental rats the number of leukocytes was reduced.
Differentiation counts revealed an Increase In neutrophlllc leukocytes
and a reduction of the Ijmphocytes. They showed low serum calcium levels
but a high level of Inorganic phosphorus; alkaline phosphatase was slightly
Increased. They also found an accumulation of mast cells: 100 cells/
mm in the femoral bone marrow, as compared to the control group: 1-2
2
mast cells/mm .
Hypercalcemia has the opposite effect on the central nervous system;
it causes depressions and sluggish reflex activities of the nervous sys
tem, and the muscles; hypercalcemia decreases the QT-interval of the
heart, causes constipation and lack of appetite probably because of the
decreased contractility of the muscular walls of the intestine.
Depressive activities start to appear above approximately 12 mg%. They
are quite marked as the calcium level exceeds about 15 mg%. When the cal
cium level exceeds about 17 mg% in the body fluids, calcium phosphate
commences to precipitate throughout the body and calcify soft tissue. This
condition appears with parathyroid poisoning.
Formation and Metabolism of Bone Tissue
Composition of Bone. Bone is composed of a tough organic matrix
which is strengthened by the deposition of calcium salts. The average com
pact bone contains by weight approximately 30 percent matrix and 70 per
cent salts. Newly formed bone tissue may consist of a considerably higher
percentage of matrix in relation to salts.
The Organic Matrix of Bone. The organic matrix of bone consists of
approximately 95 percent collagen fibers and about 5 percent ground sub
stance. The collagen fibers have a high content of glycine, proline, and
hydroxyproline. They extend in every direction but mainly in the line of
tensional force.
The ground substance consists of extracellular fluid, mucoprotein
containing sulfate, and hyaluronic acid.
The salts are composed of calcium and phosphate called hydroxyapatites,
The formula: fCa^ (P0^)g(0H")2] fta'^-Mgo'^'NaQ 3.C0^.citQ 3]^°^
The Ca/P ratio of those salts by weight is between 1.3 and 2.0.
Collagen fibers of bone are composed of repeating periodic segments
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of protein every 640 A along its length. Hydroxyapatite crystals are
placed adjacent to each segment of the fiber, bound tightly to it pre
venting the crystals and the collagen fibers to slip out of place which
is essential in providing strength to the bone. Additionally there is a
cross-linkage of segments of adjacent collagen fibers which cause the
hydroxyapatite crystals to overlap, which contributes even more to the
strength of the bone. This cross—linkage reaction includes two steps
(1) the E-amino group of lysine or hydroxylysine residue is converted into
sldehyde, catalized by an amino—oxydase, (2) the aldehyde condenses
with an aldehyde or an E-amino group on adjacent chains via a schiff
base or an aldol reaction. The collagen fibers of bone possess mainly
tensile strength while the calcium salts give to the structure mainly
compressional stength.
Bone calcification is accomplished through the work of osteoblasts
which secrete collagen and ground substance. The collagen, through
polymerization, forms collagen fibers which in turn form osteoid in which
calcium salts precipitate. Osteoblasts, which are cells lying along the
surface of the bone and being separated from mineralized bone by the
osteoid (the unmineralized matrix) become trapped and enclose themselves
and become osteocytes. A couple of days after the osteoid is formed, the
calcium salt begins to precipitate on the surface of the collagen fibers
and over a period of time they become hydroxyapatite crystals.
In the mitochondria of osteocytes there were found concentrations of
considerable quantities of calcium and phosphate which are packed Into
vesicles which break away from the mitochondria, move through the cell
wall and empty their content Into the surrounding extracellular fluid.
Those calcium-phosphate salts then attach simply to the collagen fibers
and Induce, In this way, crystallzatlon.
18Canas' study reveals that under the condition of a vitamin
deficiency In rachltlc chicks expressed on a volume basis, the cortical
bone has decreased levels of ash and of organic material. When those
chicks were treated with 8 lU per day of vitamin normal bone composi
tion was restored within seven to eight days. He found a two—fold In
crease of the specific activity of bone hydroxyprollne, following Intra-
peritoneal Injection of prollne H, over rachltlc controls during the
first four days of treatment with vitamin D. After seven to eight days
the activity of hydroxyprollne returned to normal levels. He observed
an Increased Incorporation of prollne H Into bone collagen approximately
twelve hours after the vitamin D administration and before a rise In plasma
calcium Ion concentration toward normal levels occurred. This study
Indicated that vitamin D directly affects the synthesis of bone collagen.
Another possible Involvement of vitamin D In the metabolism of collagen
6Is shown by Barnes, et al. In his radlolsotope studies using Hlyslne
he demonstrated that collagen which Is synthesized In the shafts of bones
In rachltlc rats and chicks Is similar In chain composition, however,
rachltlc animal collagen In rats and In chicks contains a higher content
of hydroxylyslne as compared to the control group which received adequate
amounts of vitamin D repletion. The general extent of lyslne hydroxylatlon
in chick revealed an increase of approximately 50 percent in both c«.l-and
«»<2-chains in the rachitic group as compared with the controls.
Calcitonin, being a protein hormone, probably interacts on the mem
brane of osteoclasts with specific receptor sites. There is an accumula
tion of cycl. AMP in the inside of the cell and this probably alters the
calcium and phosphate content, or the transport of both across the plasma
membrane.
Osteocytes may resorb surrounding bone tissue. This process is
8 9called osteocytic osteolysis, ' and is induced by PTH. Baylink, D., and
Morey, E., et al, found that calcitonin decreases the rate of peri—
lacunar mineral removal by ostocytes in thyroparathyroidcctomized rats.
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Belanger and Rasmussen reported that calcitonin antagonizes the
effect of parathyroid hormone stimulation on osteocytes and shortens
their lifespan. Those two studies indicate that calcitonin directly in
fluences the function of osteocytes.
This function of those bone cells is very important concerning the
renewing mechanism of adult bone. Bone needs to be remodeled constantly
for the following reasons:
(1) Bone needs to adjust its strength in proportion of the degree
the bone is exposed to stress.
(2) It is necessary that the bone rearranges its shape when deformed.
(3) Old bone becomes relatively weak and brittle. The bone, however,
has to maintain its normal toughness and this factor requires the constant
exchange of new organic matrix for the old one.
The rate of the deposition of bone is controlled mainly by bone stress.
The bones of athletes become significantly stronger and heavier than bone
of a sedentary person. Continual stress stimulates osteoblastic deposi
tion of bone. Deposition of bone is caused by the piezoelectric effect.
Stress or compression causes a negative electrical potential at the com
pressed side and a positive potential somewhere else on the bone. Very
tiny quantities of electrical current stimulate osteoblast activity at
the negative side. Astronauts coming back from their 8-day flight had
more than 20 percent bone loss since the pressure exerted by their body
104weight was absent. This piezoelectric effect might partially explain
the phenomenon of bone resorption in edentulous patients. Their teeth
exercised a negative pressure on the jaw bone when chewing, while immediate
dentures do not have this direct compression effect on the bone. The
rate of the calcium turnover in bone is in infants 100 percent per year;
in adults 18 percent per year. The total blood flow in bone tissue is
40approximately 200-400 ml per minute.
General Bone Resorption and Bone Resorption of the Residual Ridge
Bone is a living tissue and subject to change; it is dynamic and
35continually remodeled during the whole life. This is also stated in
Albright's^ metabolic balance theory (1947): "The structure of the human
skeleton is maintained by a steady state between bone resorption and bone
/
formation. The histophysiologic process of resorption of old bone and
replacement with new bone is called internal bone remodelling."
Bone resorption is defined as the loss of substance through physio
logic or pathologic means. It is chronic, progressive, irreversible, and
cumulative. Bone resorption in the mandible results in recession of
the alveolar crest bone with consequent tooth mobility. Bone resorption
is stimulated by the activity of parathyroid hormone and vitamin D activ
ity. It is inhibited by calcitonin and phosphate which is
synergistic. Injections of PO^ increase the secretion of calcitonin.
PO^ can prevent bone resorption and stimulate bone formation directly.
91Reynolds, 1972, in his in vitro studies demonstrated that the vitamin D
metabolite 25-HCC increases bone resorption, that PTH, heparin, vitamin A
99cause bone resorption, too. Raisz, et al, in 1972 in vitro study
demonstrated that 1,25—DHCC was 100—fold more potent in bone resorption
compared to 25—HOC on a weight basis and that a brief exposure to maximum
doses of either agent leads to prolonged bone resorption. Cholecalciferol
is inactive relative to bone resorption.
64Holick, et al, (1972) demonstrated that nephrectomy in rats com
pletely inhibits the bone calcium mobilization in response to 25-HCC
but does not inhibit 1,25-DHCC, which still causes bone resorption even
after nephrectomy.
The resorptive activity of parathyroid hormone is explained through
a release of lysosomes from osteolytic cells, osteoclasts. Microscopic
studies have revealed evidence of external osteoclastic activity as a
mechanism of gross bone resorption. ^ ■" - i ^Lysosomal enzymes could resorb
the organic matrix while acids, e.g., citrate which is produced during
glycolysis might act as a dissolver of bone salts. Stimulation of DNA
dependent RNA synthesis in existing osteoclasts without increasing their
129 101number may increase bone resorption. Raisz and co-workers in
1975 reported the localization and activity of an osteoclast activating
factor (OAF) released by normal human peripheral blood leukocytes. Like
PTH, OAF causes a rapid release of previously incorporated Ca from
fetal rat bone, after short or continuous exposure. He observed that the
bones loose both stable calcium and collagen content. The response of OAF
to the bone resorption seems to be quite similar to that of PTH. Cal-
citonin only transiently inhibits OAF which is partially inhibited by
PO^ at a medium concentration. Cortisol was a more effective inhibitor
of the OAF stimulated resorption. The administration of maximally ef
fective doses of OAF indicated that the response of OAF to that dose was
not enhanced by PTH or prostaglandin E2, however, when submaximal doses
were given PTH had some effects. He reports that OAF and PTH inhibit
collagen synthesis in fetal rat calvaria at the same concentration which
19stimulates bone resorption. Caputo reported that estrogen compounds
are unable to inhibit the bone resorption of tissue cultures induced by
OAF or prostaglandin E^.
Phosphorus depletion in relation with a normal intake of calcium in
rats caused a drop in plasma P and a rise in plasma calcium concentration
and also a rise in urinary excretion of calcium. There was a decreased
number of primary bone osteocytes and an increased number of enlarged
osteocytes, osteoclasts and osteoblasts, as a result of phosporus defi
ciency. The results show that in the young growing rat a phosphorus de
ficiency induces an augmentation of bone resorption which also occurred
in PTX rats in absence of PTH.^^
Bruin, who did a similar study, examined the effect of a diet
severely deficient in phosphate on calcium metabolism in thyroparathy-
roidectomized (TPTX) rats. In the TPTX rats severe phosphatemia was in
duced within twelve hours while in the intact group 48 hours elapsed.
Both groups developed hypercalcemia. The hypophosphatemic condition
resulted in an increased bone resorption and an inhibition of bone min
eralization. The increase in bone resorption occurred faster in the
TPTX rats.
31Feinblatt, et al, reported that the thyroid glands of chick embryos
secrete a bone resorbing factor which was not PTH. He reported that
neither thyroxine (1^) nor triiodothyronine (T^) induced a significant
bone resorption when a wide range of doses were given. Calcitonin in
hibited the activity of this bone resorbing factor. It can synergize
with PTH but not with T^, T^, PgE^ or PgE^. Dietrich^® did more work on
prostaglandins and checked them for their ability to resorb bone in an
organ culture of fetal rat bone. Prostaglandin E,F,A, and B showed to
stimulate the release of previously incorporated ^^calcium by 60 to 135
percent at maximally effective doses. Prostaglandins of the E series
proved to be 10 to 100-fold more potent than F,A, or B prostaglandins.
PgE2 stimulated bone resorption slower than PTH but caused complete re
sorption after six days in the culture system.
Bone Resorption of the Alveolar Ridge
102Victoria, et al, distinguishes three different kinds of resorp
tion: (1) parallel resorption where the labial, cranial, and lingual
bone contours have moved approximately to the same extent; (2) the
cranial-labial resorption; (3) the cranial resorption with only one main
direction of resorption. When the bone loss is rapid and abnormal in
the residual ridges, there seems to be evidence that general skeletal
QO
osteoporosis is also present and goes parallel with it.
Causes of Alveolar Bone Resorptxon
Alveolar bone resorption is one of the most significant factors in
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denture treatment. It is a common phenomenon following the extraction
of teeth. ' Henrikson and Per-Ake^^ did experimental investigations
on the pathogenesis of periodontal disease in relation to calcium de
ficiency in dogs over a 2, 4, 8, and 12-month period. Serum calcitim and
phosphorus remained within normal limits in the control dogs. In the ex
perimental dogs an early hj'pocalcemia was compensated up to four months
^socalcemia was then maintained. There was demonstrated a progres—
loss of alveolar bone, severe enough to cause a detachment of the
incisor teeth after 12 months. Histopathologic examinations revealed
progressive, moderate parathyroid changes associated with hyperfunction.
Resorption of bone occurred mainly through osteolysis. An analysis of the
calcium and phosphorus nutritional intake in man with regard to dietary
standard in different countries in relation to dietary calcium intake
within different socioeconomic classes was undertaken. A positive cor-
'^slstion between deficient calcium nutrition and periodontal disease was
established. Simple calcium deficiency and a very unfavorable calcium
to phosphorus ratio in the average human diet could explain the bone loss
aspects of periodontal disease.
It seems that a high dietary intake of phosphorus may be one cause
of bone resorption. Kelsey (1971) thinks that factors such as vitamins,
minerals, and hormones must be considered as being of secondary importance
in the etiology of bone resorption, because all body tissues are being
exposed to their influences equally. He counts factors of prime impor
tance such as extrinsic biomechanical forces, genetic influences, and
the interaction of bone and its covering membranes. Unfortunately he
does not give a clearer definition of what he understands extrinsic bio
chemical forces are.
53Jowsey on the other hand, when discussing different causes of
bone resorption, attributes some importance to phosphate. She thinks
that phosphates could cause an increase in parathyroid hormone in the
blood, which is responsible for the differentiation of the osteoclasts.
The factor of wearing dentures continuously or only part of the day seems
to be quite controversial. Kelsey^^ (1971) reported from his study that
patients wearing their dentures only by day or only occasionally during
the first year showed significantly less bone loss than those wearing
27their dentures continually. De Van (1930) reports that according to his
experience a denture inserted immediatly after the extraction of the teeth
109has a preventive effect on bone resorption. Victorin and Sobolik
report that immediate denture methods result in less absorption of the
alveolar process, and that a well constructed denture has a healing
stimulating effect on the bone and on the bone tissue.
A high protein diet causes a negative calcium balance and has to be
included as a possible factor in bone resorption. Bell^^ in his study
on rats showed that there is a shift in the route of excretion of endog-
I
enous calcium from feces to urine, and there is an increase of absorption
of dietary protein. He found that a high protein diet in rats does not
have an effect on bone resorption as long as the calcium and phosphorus
intakes are adequate. Other studies indicate that the amount of calcium
excreted in the urine is dramatically affected by the intake of protein.
In the study done by Johnson^^ (1970) in human males an increase in daily
protein from 48 to 141 g caused a two—fold increase of calcium excretion
in the urine when both the calcium and the phosphorus intake were held
constant at 1400 mg. Anand and co-workers (1974) after a study on nine
men, wrote: In all studies conducted in this laboratory, the detrimental
effect of the high protein diet was the result of greatly increased
urinary calcium without a corresponding decrease in fecal calcium...."
The amount of calcium excreted in the urine when medium and high protein
diets were fed was greater than the apparent absorption of calcium. It
has been established that the extracellular fluid calcium levels are
maintained at the expense of bone calcium and that a negative balance over
a long period of time results in diminution of bone mass and osteoporosis.
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Chu (1974) and co-workers reviewed several studies on the same
subject and found ever^iwhere a markedly positive correlation between pro
tein intake calciuria. "Although the response was not linear, varying
protein intake from 0 g to 90 g N per day results in approximately an
800 percent increase in calcium excretion irrespective of calcium intake.
This effect of protein occurred in all our studies of individuals, and
was observed also with pure L-amino acid mixtures.
39Garnet (1970) reported that starvation has a reso.."ptive effect.
Through starvation he induced ketoacidosis in five humans. During the
14 weeks of the study the mean daily calcium loss in the urine was as
high as 560 mg. The greatest calciiim excretion occurred between the
third and fourth week.
27Infection as a cause of bone resorption was reported by De Van
(1930). He thinks that atrophy of the alveolar process is primarily due
to trauma followed by infection.
Suggestions for the Treatment and the Prevention of Bone Resorption
54Jowsey (1972) mentions different possible ways of treating osteo
porosis. She reports that estrogen supplements do not seem to work. Cal-
53citonin decreases the serum calcium ion concentration and serum phos
phate levels which would result in an increased secretion of parathyroid
hormone and a resulting increased bone resorption. An oral supplementa
tion of calcium was not very successful in the past and daily infusions
of calcium over a three week period have, however, resulted in a decrease
in bone resorption.
Fluoride seems to have a stimulating effect on bone formation' in
adults. According to her report, excellent results in animals have been
reported when a mixture of fluoride, calcium, and vitamin D were admin
istered. An increase in bone formation was seen. When the calcium part
was about 600 mg or more bone resorption was significantly decreased. The
higher the calcium part the lesser was the bone resorption. A recommended
dosage is; sodium fluoride 50 mg/day; calcium as carbonate or gluconate
600-1000 mg/day; and vitamin D about 50,000 lU two times/week.
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Hanson in Sweden tried the formula given above by Jowsey on nine
osteoporotic women at the age range of 51-65 years for 1.5 to 2 years, and
measured their lumbar vertebra by dualphoton absorptiometry. All of the
women had at least one vertebral fracture and a spinal x-ray on which low
bone density was determined. No signs of hypercalcemia, hyperphosphatemia,
or hypercalciuria were marked. Five patients completely lost their pains,
four had only slight complaints of back pains but much improved when com
pared to the pain before the treatment. No visible changes in bone density
occurred on the x-ray of the spine or femoral neck. Absorptiometric
results on the scans of the third and fourth lumbar vertebra, however,
showed that an increase of bone mineral content was achieved in eight
treated women.
30Ericsson and Ekberg in 1975 provoked general and alveolar osteo—
penia in rats. He fed them a calcium-deficient, low-protein, high-sucrose
for varying periods. The rats were given either distilled water or
2000 ppm Ca containing water, 40 ppm fluoride, or both. The bone density
on the calcium deficient diet was greatly improved by giving either Ca or
Ca and F. A tendency to higher mineral density was observed with Ca+F.
Fats conditioned by a high fluoride diet showed much higher resistance
to mineral depletion caused by a calcium-deficient diet than the control
rats on the same diet without F. He found that the "alveolar bone generally
reacted more strongly than the femoral bone to both deprivation and sup
plementation, and the tissue between the roots of one molar (M2) more than
the tissue between two molars (Ml-2)." Jowsey's comment on the failure
of estrogens and androgens to inhibit bone resorption was further in-
19vestigated by Caputo, et al, using a tissue culture, of from 19 day fetal
rat long bone shafts. He found that corticosterone, testosterone, estradiol,
and estrone did not inhibit the release of ^^Ca. Cortisol, however, in-
hibited PTH—stimulated resorption and resorption in the control group.
Lutwak ̂  (1971) in his study concentrated on the effect of bone re
sorption in the mandible. He reported that a dietary supplement of 1000 mg
of calcium during six months in hinnan subjects reversed bone loss and
resulted in the disappearance of the clinical signs. Urinary calcium
increased but remained within accepted ranges. There was a clear increase
in bone density as measured by x-ray: (1) in the mandible; (2) in the
alveolar bone. There were no significant changes in the blood chemistry
in none of the subjects. In his study in 1974, Lutwak^^ used 90 patients
with mild periodontal disease. They received either 1000 mg of calcium
supplement or a placebo. After 12 months of treatment no significant
differences in bone density could be measured in ulna or radius during
this period. Significant changes, however, were seen in the jaw. The
group receiving the placebo showed no significant change over the 12 month
period. The group receiving the calcium supplement, however, showed an
appoximately 12.5 percent statistically significant increase in bone den
sity as a result of supplementation vrf.th dietary calcium.
DESCRIPTION OF THE INVESTIGATION
The purpose of this study was to investigate the possible effects
of a calcium and vitamin D dietary supplement on the resorption of alveolar
bone following tooth extractions in human subjects.
The subjects of this study were 46 denture patients from the prostho-
dontic clinic of the Dental School, Loma Linda University. All of the
patients selected were scheduled for the extraction of several natural
teeth and the immediate placement of dentures. Only patients who were
interested in the project and who cooperated in providing information and
in meeting appointments for check-ups were included and are reported in
this study. All were Caucasian.
Table 1 shows the distribution of subjects in the study groups and
numbers of extractions for patients in the two groups.
Medication and Dosage
Throughout the study period of one year, each subject received a
medication in tablet form. Twenty-three of the subjects took 3 tablets
daily of a preparation containing 250 mg of calcium (calcium carbonate
from oyster shell) and 125 US? units of vitamin D^ (ergocalciferol).
Each subject taking the study drug thus received a daily supplement of
750 mg of calcium and 375 units of vitamin D. Twenty-three of the
subjects took the same number of tablets of a placebo medication. The
tablets of the study drug and the placebo were identical in appearance.
and were identified by code numbers only. This was a double-blind study,
as neither the investigators nor the patients know the code, which was
sealed until the end of the study. The patients were not grouped until
the code was revealed.
Radiographic Examination
Panoramic radiographs of the patients jaws were taken several times
during the study; before extractions, a few days after extractions, and
at approximately 3 month intervals until the final radiograph one year
after the extractions.
Panoramic radiographs record the patient's upper and lower jaws
and related anatomic structures, such as the maxillary sinuses, from the
left condyle around the entire arch of the jaws to the right condyle, on
a single 5 x 12 inch film. The panoramic radiographs used in this study
were taken with a S. S. White "Panorex" machine. The film used for all of
the pictures was Du Pont "Chronex 2 DC". The uniform exposure time was
18 seconds. Kilovoltage varied from 75 to 90 KVP and the current varied
from 10 to 13 ma depending on the size of the patient's head, and was
determined from standard reference tables.
The Panorex machine utilizes a constantly moving pencil-thin x-ray
beam which is aimed at a constantly moving film holder as the x-ray tube
head and the film holder revolve around the patient's face as programmed
by the machine. The x-ray exposure to any one area of tissue is minimized
and is well within allowable limits, actually less than half of the ex
posure required by a standard full-mouth series of dental radiographs.
Intensifying screens are used in the film cassettes to further reduce the
radiation requirement. All patients were carefully protected by lead
aprons and shielding during the x-ray exposures.
To Insure consistency between successive films, each subject was
seated In the same position In the machine, which has a fixed chair, for
each film. AS. S. White "Panocentrlc" head positioner, which orients
the patient's face and chin In the same planes each time, was used to
position the subject's head for each exposure.
To further achieve consistency, all of the more than 200 radiographs
were taken by one of two professional dental assistants who were trained
In the operation of the Panorex x-ray unit, and all of the film developing
was done by automatic processing machines.
Radlographlc Data
At the end of the study, the Immediate post-surgical panorex film
and the 12-month post-surgical film were compared to obtain data on the
amount of bone resorptlon which had occurred In the jaws during the one-
year Interval between the radiographs.
To record the changes In the height and outline of the alveolar
bone between the dates of the two films, the following method was used:
The first radiograph was placed on a lighted view box, and a sheet
of transparent tracing film was placed over It. Anatomic landmarks such
as the outline of the maxillary sinuses, the shadows of the zygomatlc
and palatal bones, the lower borders of the mandible, the mental fora
mina, and the mandlbular nerve canals were traced with black pencil.
Also, the outlines of the fresh extraction sockets In the bones were
traced with broken black lines. Then, the outlines of the alveolar proc-
esses In the quandrants of the jaws where teeth were extracted were traced
with a sharp red pencil.
Next, the same tracing film was superimposed over the 12-month post-
surgical radiograph, and oriented correctly by means of the anatomic land
marks previously recorded. Then the outlines of the alveolar processes
as shown in this second radiograph were traced with a sharp blue pencil.
The space between the red tracing and the blue tracing represented the
loss of vertical height of the bone during the 12-month interval.
In order to obtain quantitative data which would represent the amount
of bone resorption shown in the radiographs, the area between the red and
blue tracings, extending 5 cm on each side of the midline, was measured
by means of a polar compensating planimeter (Charles Bruning Company). The
polar planimeter is a precision instrument used by engineers, statisticians,
and physicists for the accurate measurement of areas of plane surfaces
which have irregular borders.
The data obtained from the measurements of the areas on the tracings
are expressed in square millimeters, but it must be emphasized that these
figures represent only a relative measurement of the loss in vertical
height of the jaw bones due to resorption of the alveolar process. No
method of measuring actual total quantitative loss of bone tissue has yet
been found. Still, the data obtained from the measurement of the change
in vertical height of the bone are usedful and reliable for a comparative
study such as this one.
Since a greater amount of bone loss is to be expected in the im
mediate area of the recent extractions, or in other words, since there is
an expected correlation between the number of extractions and the amount
of bone change, the nmnber of extractions was recorded for each quadrant
for each subject, so that this data could also be considered in the anal
yses of the results.
Dietary Data
It was also planned to investigate possible correlations between
dietary calcium and phosphorus and the amount of bone resorption revealed
by the radiographic study; so an analysis of each patient's diet was per
formed approximately midway in the 12-month study period. The time for
the dietary analysis was selected so that the patients would have time to
return to their habitual eating patterns following the extraction of their
teeth and the obtaining of new dentures. None of the subjects at this time
complained of inability to eat normally.
A 7-day diet record was provided by each subject, on a form provided
by the investigators. The patient received oral and written instructions
on the procedure. The completed records were reviewed with the patient
so that any ambiguous notations were clarified.
The dietary data was reorganized on work sheets, where each food
item was given a code number corresponding to the food item numbers from
the U. S. Department of Agriculture Handbook No. 456, Nutritive Value of
American Foods. The total weekly amount of each food item was also cal
culated and recorded in grams.
The coded food data was transferred to punch cards on a keypunch
machine. The punched cards were then fed into an IBM 370-158 computer
which had been programmed to analyze the patient's dietary date by com
paring the patient records with stored reference data from the Handbook
No. 456.
The resulting printout provided weekly and daily average intakes
15 nutritional factors. Besides giving the dietary intake of calcium
and phosphorus for the present study, the printouts provide data for
future investigations of possible correlations with many other dietary
factors.
Correlation of Denture Treatment
Following placement of immediate dentures at the time of extractions
and at the beginning of the study period, each patient was seen by a den
tist at regular intervals to make sure that the dentures were satisfactory.
The dentures were adjusted and relined whenever necessary so that, through
out the study period, no complaints of poor fit or denture irritation were
made. All of the dentures for all of the study subjects were judged to
fit well and to function well by both patients and dentists, so "poor
fitting dentures" would not be a variable factor in the study.
Analysis of the Data
After all of the data for all subjects had been collected and re
corded, the medication code was unsealed and the subjects were divided
into two groups depending on whether they had received the study medica
tion (calcium and vitamin D) or the placebo.
Since it is to be expected that the amount of bone resorption follow
ing extractions would vary according to the number of extractions done for
any patient, the basic analysis planned was to determine the average bone
loss per extraction for each group.
Also, since the rate of resorption is believed to vary between the
upper jaw and the lower jaw, the analysis was planned to differentiate
between the bone loss for upper extractions and lower extractions.
It was also desirable to know whether or not the patient's dietary
calcium and phosphorus intake (with, and without, the study supplement)
was correlated with the amount of observed bone loss; so an analysis with
this data as a variable was also performed.
All of the data was tabulated and transferred to punch cards which
were processed by computer to provide the results.
RESULTS
I gives the demographic information about the patients involved in
the study.
Table I. Demographic data of the study population
Study Group Control Group
Sex (% males; % females) M:34%; F':15% M:28%; F:23%
Mean + SD Mean + SD
Age 56.3 + 11.9 59.1 + 9.5
Number of Extractions (UM) 6.8 + 2.2 6.0+ 1.9
Number of Extractions (LM) 8.8 + 3.0 6.9+ 2.6




1160.9 + 784.0 mg* 680.0 + 273.2 mg*
1699.1 + 787.5 mg 1138.1 + 352.2 mg
*values do not imclude the calcium from supplement.
(UM=Upper Mouth; LM=Lower Mouth; T=Total)
The study and control groups are comparable on the variable of age.
The groups did not appear to be comparable on the variables of; sex, num
ber of total extractions , dietary calcium and phosphorus. Because of the
group differences in number of extractions, the variable: Bone Loss/
Extractions was calculated from the data. These results are tabulated in
Table II.
Table II. Ratio between bone lo^s and number of extractions
(in mm )
Study Group Control Group










The variables: sex, age, number of extractions, dietary calcium and
phosphorus were included in the analysis of the group differences with
respect to bone loss in two stages.
Ill the first linear model used to analyze our data we used bone loss
as the dependent variable and: group, sex, age, and the number of extrac
tions as covariates. The results of the analysis are shown in Table III.
Table III. F- values for general linear hypothesis
Maxillary Mandibular Total
Group 14.84* 13.21* 11.87*
Sex 1.30 3.31 2.83
Age 1.87 0.80 3.46
Number of Extractions 7.25* 11.91* 9.93*
* Significant at the 0.01 level
An additional analysis was done using bone loss as dependent variable.
Dietary calcium and phosphorus were included as well as group age, and the
number of extractions, as covariates. The results of this analysis are
summarized in Table IV.
Table IV. F- values for the general linear hypothesis,
including calcium and phosphorus as covariates
Maxillary Mandibular Total
Group 6.52** 5.40** 6.33**
Sex 1.04 1.88 3.17
Age 0.53 0.015 1.87
Number of Extractions 6.46** 5.65** 10.03*
Dietary Calcium 0.67 0.64 0.81
Dietary Phosphorus 0.38 0.72 0.98
* Significant at the 1% level.
** Significant at the 5% level.
The statistical analysis of total bone loss showed that there is a
significant difference (p = .01), between the groups with respect to bone
loss. Group A, the experimental group, did show lesser bone resorption
than group B, the control group. The variables: sex, age, dietary cal
cium and dietary phosphorus intake did not account for significant dif
ferences in bone loss. However, the number of extractions did show a
significant difference for both groups at the 1% level. The amount of
bone loss was significantly related to the number of extractions for each
of the groups.
With respect to the upper mouth (maxilla), we found similar results.
There was a significant difference in bone loss between the two groups
at the 0.01 level. Sex of the participants and age did not significantly
effect the groups. Neither did the intake of calcium and phosphorus show
any significance.
With respect to the lower mouth (mandible), again we were able to
demonstrate a significant difference concerning bone loss between the two
groups at the 1% level. Sex, age, calcium, and phosphorus intake did not
show a significant influence on bone loss.
(LS means Level of Significance)
J004- Upper Mouth
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Graph V. The only significant difference in group 1,3 of
all graphs
DISCUSSION
In this double blind study, the effect of a dietary supplement con-
®^bing of 750 mg of calcium and 375 lU of vitamin D, on the prevention
of bone resorption was compared to the effect of a placebo in the control
group. We found a preventive effect in the experimental group, which
showed significantly less bone resorption of the mandibular and the maxil
lary ridge as compared to the control group.
Although the two groups differed in their dietary calcium and phos
phorus intake, the analysis demonstrated that the differences in mineral
intake within the two groups did not account for the difference in bone
loss between the two groups. Dietary calcium and phosphorus intake ac
count for some of the group differences in terms of bone loss and should
not be neglected. But the analysis indicates that these differences are
not the total explanation for the difference in bone loss. Since the cal
cium intake is only partially accountable for the lesser bone loss, the
vitamin D supplementation is likely to furnish an explanation for and
account for the rest of the difference in bone loss. This would go paral
lel with the results of studies of other investigators as mentioned in
the literature review. The graphs as shown above do not show statistical
significance except one, but they nicely indicate the trend of the in
creasing amount of bone resorption as compared to the number of extrac
tions .
There were no significant differences found with respect to bone
loss when the amount of resorption at the maxilla was compared to the
resorption on the mandible. On both sides approximately similar amounts
of bone matrix were lost.
When analyzing the x—rays for bone loss by comparing the first x—ray
taken with the last x—ray, we had to face the problem that there were
slight differences due to the position of the patient's head and the
moving chair of the panorex x-ray instrument when taking the last x-ray.
Therefore, we excluded from the study all those patients whose last x-ray
showed differences in the distance of the landmarks of more than 2 mm.
SUMMARY
In this double blind study we compared the effects of a dietary sup
plement consisting of 375 lU of vitamin D and 750 mg of calcium/day, with
a placebo, on the prevention of bone loss in two different groups. We
were able to demonstrate that the number of extractions were positively
related to the amount of bone loss. We also found that the supplement
did retard bone resorption significantly. The fact that the experimental
group had a higher intake of calcium and phosphorus did account for some
preventive effect on bone loss but could not account for the whole dif
ference of bone loss between the two groups. We therefore concluded
that a calcium-vitamin D dietary supplement is effective in significantly
retarding the resorption of bone matrix on the maxilla and mandible.
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